Merck says study shows COVID-19 drug causes quick reduction in virus ...United Arab Emirates

Washington:- U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in infectious virus in its phase 2a study among participants with early COVID-19. “The secondary objective findings in this study, of a quicker decrease in infectious virus among individuals with early COVID-19 treated with molnupiravir, are promising,” said William Fischer, Associate Professor of Medicine at the University of North Carolina School of Medicine, in a statement from the companies. Immune response The antiviral is being currently tested in a Phase 2/3 trial that is set to be completed in May. Merck decided to fo

Hence then, the article about merck says study shows covid 19 drug causes quick reduction in virus was published today ( Monday 15/03/2021 - 10:46 PM ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Merck says study shows COVID-19 drug causes quick reduction in virus )

Also on site :

• Slate Auto says each $24,950 electric pickup truck will be profitable as it aims to be cash-flow positive next year
• Trump claims consumers are being ‘gouged’ by gas companies and orders DOJ price probe, as Bessent warns U.S. must avoid ‘foreign chokepoints’
• Crocs’ Platform Sandals With 'Squishy Cloud Comfort' and 'Excellent Arch Support' Are 60% Off for Amazon Prime Day